Survival association of GLP-1 receptor agonists and SGLT2 inhibitors in bladder cancer patients. Kohler J, Buck L, Schliesser P, Weische O, et al. Urol Oncol 2026;44:92-100.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kohler J, Buck L, Schliesser P, Weische O, et al. Survival association of GLP-1 receptor agonists and SGLT2 inhibitors in bladder cancer patients. Urol Oncol 2026;44:92-100.
PMID: 42224918